HeartFlow, Inc. has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommenda...
Singapore – Aiming to close its deal for Shire on Jan. 8, Japanese drugmaker, Takeda Pharmaceutical will ...
Royal Philips, a global leader in health technology, has announced a collaboration with Japanese healthcare informatics ...
A research team from Kyoto University, Japan has conducted the world’s first transplant of induced pluripotent ste...
MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...
Hong Kong Science and Technology Parks Corporation (HKSTP) announced its fruitful participation in promoting Hong K...
Japanese drugmaker Kissei Pharmaceutical has acquired exclusive rights to develop and commercialize Tavalisse (fostamati...
Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. ...
Mitsui Chemicals, Inc. and Chitose Group, a group of biotechnology startups have jointly launched the "0 to 1 Project" a...
NEC Corporation and Transgene have announced the signing of a Memorandum of Understanding (MoU) for a strategic collabor...
Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...
Singapore – Mesoblast announces that Japanese licensee JCR Pharmaceuticals Co. Ltd. plans to seek a new...
Johnson & Johnson has announced that they have agreed with Ci:z Holdings Co., Ltd. a Japanese company focused on the...
Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., have announced that the t...
Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo have concluded a collaborative rese...
A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physi...
Daiichi Sankyo Company, recently announced that it has submitted a New Drug Application (NDA) to Japan’s Min...
Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy a...
